Work

Application of functional genomics in the production of viral biopharmaceuticals: vaccines and vectors for gene therapy

Year: 2012
Type: dissertation
Abstract: Retrovirus (RV) based biopharmaceuticals comprise several valuable bioproducts such as gene therapy vectors, recombinant vaccines and replicative-competent particles for oncolytic therapy. However, RV manufacture faces several challenges, particularly the low yields of current producer cell lines and the high content of non-infective particles (an average of 1 in every 100 total viruses produced are infective), contaminating the viral preparations. The identification and manipulation of the metabolic requirements for improved virus production is the scope of this project. In this context, this master thesis proposed to i) validate metabolic pathways recruited under a virus production state – previously identified by transcriptional profiling – by culture medium manipulation and ii) implement a novel method to screen for high-producing clones after gene metabolic engineering. Medium manipulation enabled increased titers from 1.3 to 2.1 fold upon isolated medium supplementation strategies, reaching a synergistic effect with their combination of 6 fold increase. The improvement in RV production was not associated to increased viral genes expression; it was partially due to higher viral vector preparation quality (enhanced half-life for 2-3 hours and higher infectious particles per total particles content) and to an enhanced metabolic status of the producer cell. For the screening method a novel protocol was implemented taking advantage of split proteins technology enabling the isolation of the high-titer clones from the producer population by the assessment of their titers in the first stage of clone isolation - Single Step Cloning-Titration. Validated metabolic pathway will now be object of gene-based metabolic engineering which, resorting to the implemented protocol, can be conducted in a large-scale multi-gene approach, never attempted before. This work directly contributes for improved cell line development in RV manufacture and encompasses pioneering steps in mammalian cell multi-gene metabolic engineering.
Author: Ana S. F. Oliveira
Language: English
Open Access status: green
OpenAlex ID: W1757831565
Cites: 60
Cited by: 1
Related to: 10